Adial PharmaceuticalsADIL
13F holders, Q1 2024 (March 31)15holders
1famous investor
$1.33avg. 13F price*
At the end of Q1 2024, 15 institutions reported holding Adial Pharmaceuticals Inc. (ADIL) in their 13F filings. The largest holders were Renaissance Technologies ($68K), Manchester Capital Management LLC ($64K) and HRT Financial LP ($47K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Adial Pharmaceuticals Inc.
- CUSIP
- 00688A205
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $74K |
| Exits | 4 | $329K |
Ownership 15 holders
| Renaissance Technologies | 0.00% | Add +120.3% | 51,100 | $68K |
| Manchester Capital Management LLC | 0.01% | No change | 48,097 | $64K |
| HRT Financial LP | 0.00% | New | 35,767 | $47K |
| Virtu Financial LLC | 0.00% | New | 20,469 | $27K |
| BlackRock Inc. | 0.00% | No change | 7,639 | $10K |
| UBS Group AG | 0.00% | Add +58.1% | 5,726 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +9.2% | 4,625 | $6K |
| Osaic Holdings, Inc. | 0.00% | Add +303.2% | 2,500 | $3K |
| Headlands Technologies LLC | 0.00% | New | 64 | $85 |
| Abound Wealth Management | 0.00% | No change | 27 | $36 |
| Morgan Stanley | 0.00% | Add +66.7% | 15 | $20 |
| Wells Fargo & Company | 0.00% | Add +37.5% | 11 | $15 |
| Qube Research & Technologies Ltd | 0.00% | No change | 8 | $11 |
| Royal Bank of Canada | 0.00% | Reduce -50.0% | 19 | $0 |
| Benjamin F. Edwards & Company, Inc. | 0.00% | No change | 40 | $0 |
"% of holder's portfolio" is ADIL's weight in each manager's 13F, not the share of Adial Pharmaceuticals Inc. the manager owns.